Case Report of CCDC149–ALK Fusion: A Novel Genetic Alteration and a Clinically Relevant Target in Metastatic Papillary Thyroid Carcinoma

H Lee, V Krishnan, LJ Wirth, C Nucera, M Venturina… - Thyroid, 2022 - liebertpub.com
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, usually with an
indolent course. ALK fusions are rare in PTC but may give rise to a more aggressive …

Case Report of CCDC149-ALK Fusion: A Novel Genetic Alteration and a Clinically Relevant Target in Metastatic Papillary Thyroid Carcinoma.

H Lee, V Krishnan, LJ Wirth, C Nucera… - … : Official Journal of the …, 2022 - europepmc.org
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, usually with an
indolent course. ALK fusions are rare in PTC but may give rise to a more aggressive …

[HTML][HTML] Case Report of CCDC149–ALK Fusion: A Novel Genetic Alteration and a Clinically Relevant Target in Metastatic Papillary Thyroid Carcinoma

H Lee, V Krishnan, LJ Wirth, C Nucera, M Venturina… - Thyroid, 2022 - ncbi.nlm.nih.gov
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, usually with an
indolent course. ALK fusions are rare in PTC but may give rise to a more aggressive …

Case Report of CCDC149–ALK Fusion: A Novel Genetic Alteration and a Clinically Relevant Target in Metastatic Papillary Thyroid Carcinoma.

H Lee, V Krishnan, LJ Wirth, C Nucera… - …, 2022 - search.ebscohost.com
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, usually with an
indolent course. ALK fusions are rare in PTC but may give rise to a more aggressive …

Case Report of CCDC149-ALK Fusion: A Novel Genetic Alteration and a Clinically Relevant Target in Metastatic Papillary Thyroid Carcinoma

H Lee, V Krishnan, LJ Wirth… - … : official journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, usually with an
indolent course. ALK fusions are rare in PTC but may give rise to a more aggressive …

Case Report of CCDC149-ALK fusion: a novel genetic alteration and a clinically relevant target in metastatic papillary thyroid carcinoma.

H Lee, V Krishnan, LJ Wirth, C Nucera… - … : Official Journal of the …, 2022 - europepmc.org
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, usually with an
indolent course. ALK fusions are rare in PTC but may give rise to a more aggressive …